Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025)

Pulmonx (LUNG) has 7 years of Income from Continuing Operations data on file, last reported at 13929000.0 in Q3 2025.

• On a quarterly basis, Income from Continuing Operations rose 1.52% year-over-year to 13929000.0 in Q3 2025; TTM through Sep 2025 was 56725000.0, a 0.72% increase from a year earlier, with the FY2024 full-year figure at 56394000.0, up 7.31% from the prior year.
• Income from Continuing Operations for Q3 2025 stood at 13929000.0, up from 15173000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for LUNG reached as high as 10137000.0 in Q3 2021 and fell as low as 16155000.0 in Q2 2023.
• Historically, Income from Continuing Operations has averaged 14125105.26 across 5 years, with a median of 14172000.0 in 2022.
• Across the five-year window, Income from Continuing Operations plunged 162.62% in 2021 and rose 13.22% in 2024, its largest moves.
• Year by year, Income from Continuing Operations stood at 13006000.0 in 2021, then decreased by 9.87% to 14290000.0 in 2022, then grew by 2.81% to 13888000.0 in 2023, then climbed by 5.13% to 13175000.0 in 2024, then retreated by 5.72% to 13929000.0 in 2025.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 13929000.0 in Q3 2025, 15173000.0 in Q2 2025, and 14448000.0 in Q1 2025.